Design and synthesis of novel antibacterial hybrids combining quinoline and thiazole moieties
Future Medicinal Chemistry · 2026
DOI: 10.1080/17568919.2026.2658010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Mostafa M A Aref und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, TX, USA. Hauptthemen laut MEDLINE: Quinolines, Thiazoles, Anti-Bacterial Agents, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University.
Abstract (Originalsprache)
AIM: The emergence of bacterial resistance underlines the urgent need for antibacterial agents with novel structures and mechanisms. We designed quinoline-thiazole hybrids by combining two privileged pharmacophores with established antibacterial properties.. METHODS: Fifteen novel derivatives were synthesized from quinoline-thiosemicarbazone precursors via reactions with phenacyl bromide and chloroacetic acid, followed by aldehyde condensation. Structures were confirmed by spectral analyses. Antibacterial activity was evaluated against MSSA, MRSA, and VRSA strains, and the most potent compounds were further assessed for antibiofilm activity, Cytotoxicity against WI38 fibroblasts (MTT assay), and potential inhibition of D-alanine-D-alanyl carrier protein ligase (SaDltA) via molecular docking. RESULTS: Nine compounds demonstrated potent activity against MSSA (MIC: 0.59-2.2 µM) and MRSA (MIC: 1.08-9.08 µM), comparable to vancomycin (0.34 and 1.35 µM, respectively). Notably, several derivatives surpassed vancomycin in antibiofilm activity against both MSSA and MRSA. Cytotoxicity assessment revealed a favorable safety profile (IC₅₀: 410.13-3246.1 µM). Molecular docking demonstrated significant SaDltA binding (ΔG: -13.29 to -7.75 kcal/mol), suggesting a plausible mechanism for MRSA inhibition. CONCLUSION: Quinoline-thiazole hybrids exhibited potent antibacterial and antibiofilm activities, with favorable drug-like properties, positioning them as promising candidates for the treatment of multidrug-resistant staphylococcal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, TX, USA.
- Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
- Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Egyptian Drug Authority (EDA), Giza, Egypt.
Förderung
- Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University
Zitieren
APA
Aref, M. M. A., Al-Hussain, S. A., Abdel Halim, A. S., Ali, H. I., Zaki, M. E. A., Abdelhamed, M. N., & Muhammad, Z. A. (2026). Design and synthesis of novel antibacterial hybrids combining quinoline and thiazole moieties. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2658010
Vancouver
Aref MMA, Al-Hussain SA, Abdel Halim AS, Ali HI, Zaki MEA, Abdelhamed MN, et al. Design and synthesis of novel antibacterial hybrids combining quinoline and thiazole moieties. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2658010
BibTeX
@article{Aref2026,
author = {Aref, Mostafa M A and Al-Hussain, Sami A and Abdel Halim, Alyaa S and Ali, Hamed I and Zaki, Magdi E A and Abdelhamed, Mennatullah N and Muhammad, Zeinab A},
title = {Design and synthesis of novel antibacterial hybrids combining quinoline and thiazole moieties},
journal = {Future Medicinal Chemistry},
year = {2026},
doi = {10.1080/17568919.2026.2658010}
}
EUVIMED